Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- Clinical Study Details
A Study to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil (MMF) in Participants With Pemphigus Vulgaris (PV)
-
Autoimmune Disorder
- Results
-
Download -
Study results
LPS WA29330 PEMPHIX Interim Results December 20219 English
(PDF, 0.5 MB)
LPS WA29330 PEMPHIX Interim Results December 2019 South America Spanish
(PDF, 1.4 MB)
LPS WA29330 PEMPHIX Interim Results December 2019 Turkish
(PDF, 1.1 MB)
LPS WA29330 PEMPHIX Interim Results December 2019 Brazil Portuguese
(PDF, 0.8 MB)
LPS WA29330 PEMPHIX Interim Results December2019 French
(PDF, 0.8 MB)
LPS WA29330 PEMPHIX Interim Results December 2019 German
(PDF, 0.7 MB)
LPS WA29330 PEMPHIX Interim Results December 2019 Hebrew
(PDF, 0.9 MB)
LPS WA29330 PEMPHIX Interim Results December 2019 Spanish
(PDF, 1.0 MB)
LPS WA29330 PEMPHIX Interim Results December 2019 Italian
(PDF, 1.1 MB)
LPS WA29330 PEMPHIX Final Results July2020 English
(PDF, 0.5 MB)
LPS WA29330 PEMPHIX Final Results July 2020 Brazil Portuguese
(PDF, 0.5 MB)
LPS WA29330 PEMPHIX Final Results July 2020 French
(PDF, 0.5 MB)
LPS WA29330 PEMPHIX Final Results July 2020 German
(PDF, 0.5 MB)
LPS WA29330 PEMPHIX Final Results July 2020 Hebrew
(PDF, 0.5 MB)
LPS WA29330 PEMPHIX Final Results July 2020 South America Spanish
(PDF, 0.5 MB)
LPS WA29330 PEMPHIX Final Results July 2020 Spanish
(PDF, 0.5 MB)
LPS WA29330 PEMPHIX Final Results July 2020 Turkish
(PDF, 0.5 MB)
LPS WA29330 PEMPHIX Final Results July 2020 Italian
(PDF, 0.6 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com